Reigin Zawadzki
Oficial de Recursos Humanos en CARIBOU BIOSCIENCES, INC. .
Origen de la red de primer grado Reigin Zawadzki.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Reigin Zawadzki a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| Bryn Mawr College | College/University | Undergraduate Degree | |
| SEER, INC. | Biotechnology | Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Miami Leonard M. Miller School of Medicine | College/University | Doctorate Degree | |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Miscellaneous Commercial Services | Director/Board Member | |
| ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
| Drh Consulting LLC | Chief Executive Officer | ||
Consolidated Edison Company of New York, Inc.
 Consolidated Edison Company of New York, Inc. Electric UtilitiesUtilities Consolidated Edison Co. of New York, Inc. engages in the distribution of electric power services. It operates through the following segments: Electric, Gas, and Steam. The company was founded in 1884 and is headquartered in New York, NY. | Electric Utilities | Chief Tech/Sci/R&D Officer | |
Susan G. Komen for the Cure
 Susan G. Komen for the Cure Miscellaneous Commercial ServicesCommercial Services Susan G. Komen for the Cure conducts research for breast cancer treatment. It is an non-profit organization engages in breast cancer cure research and fund raising activities. The company was founded by Nancy Goodman Brinker in 1982 and is headquartered in Dallas, TX. | Miscellaneous Commercial Services | Chief Executive Officer | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| The Hastings Center | Director/Board Member | ||
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Doctorate Degree | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BHLF LLP | Founder | ||
| University of California, Irvine | College/University | Undergraduate Degree | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | General Counsel | |
General Chemical Corp.
 General Chemical Corp. Industrial SpecialtiesProcess Industries General Chemical Corp. supplies specialty chemicals. Its soldering fluxes are designed to reduce or virtually eliminate corrosion in soldered joints. The firm’s paint strippers are used for substrate such as aluminum, ferrous metals and other surfaces. The company was founded in 1980 and is headquartered in Brighton, MI. | Industrial Specialties | Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| BOUNDLESS BIO, INC. | Biotechnology | Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Public Communications Contact | |
The European Hematology Association
 The European Hematology Association Miscellaneous Commercial ServicesCommercial Services The European Hematology Association (EHA) is a non-profit professional association that advocates and collaborates for hematology. The EHA is based in The Hague, Netherlands. EHA serves as the face and voice of hematology and hematology professionals in Europe to promote the interests of its members in policy, regulatory, and scientific areas. The association engages with the EU institutions, scientific networks, and national societies. EHA creates clinical practice guidelines for the diagnosis and treatment of hematologic diseases and organizes an annual congress. The association also offers fellowships, grants, and computational biology training for scholars who want to build successful careers in hematology research. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Puget Sound | College/University | Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
| Dow Medical College | College/University | Doctorate Degree | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Estados Unidos | 45 |
| Canadá | 4 |
| Dinamarca | 2 |
| Países Bajos | 2 |
| Pakistán | 2 |
Sectorial
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 8 |
| Health Services | 3 |
| Distribution Services | 2 |
Operativa
| Director/Board Member | 38 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 17 |
| Undergraduate Degree | 16 |
| Chief Tech/Sci/R&D Officer | 16 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Scott Braunstein | 26 |
| Andrew Guggenhime | 13 |
| Natalie Sacks | 13 |
| Barbara McClung | 12 |
| Dara Richardson-Heron | 11 |
| Timothy Kelly | 9 |
| Syed Rizvi | 9 |
| Rachel Haurwitz | 7 |
| Nancy Whiting | 7 |
| Ruhi Khan | 6 |
| Ran Zheng | 6 |
| Steven Kanner | 5 |
| David Johnson | 5 |
| Jason O’Byrne | 5 |
| Elaine Alambra | 3 |
- Bolsa de valores
- Insiders
- Reigin Zawadzki
- Conexiones Empresas
